Product Information
DEXTROAMP-AMPHETAM 7.5 MG TAB is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.2612 per EA under NDC 42858072201. Its NADAC has been published 238 times since Feb 2, 2022.
FDA first approved this application on Jan 13, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHETAM 7.5 MG TAB
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
1.875; 1.875; 1.875; 1.875 mg/1; mg/1; mg/1; mg/1
Manufacturer
Rhodes Pharmaceuticals L.P.NDC
42858072201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA213111FDA Approved
1/13/2021
TE Code
AB
On Market Since
9/9/2021
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has been published 238 times since Feb 2, 2022, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2612 per EA |
|---|---|
| All-time high | $0.6705 (Nov 15, 2023) |
| All-time low | $0.1857 (Nov 20, 2024) |
| 52-week high | $0.3257 |
| 52-week low | $0.2582 |
| Median price | $0.3802 |
| Average price | $0.3842 |
| Largest weekly change | +58.7% (Sep 21, 2022) |
| Weeks tracked | 238 |
| Tracking since | Feb 2, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHETAM 7.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAM 7.5 MG TAB, manufactured by Rhodes Pharmaceuticals L.P., is $0.2612 per EA (NDC 42858072201), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHETAM 7.5 MG TAB changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has declined 44.0%. It has been tracked across 238 weekly CMS publications since Feb 2, 2022.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAM 7.5 MG TAB?
Since Feb 2, 2022, the NADAC for DEXTROAMP-AMPHETAM 7.5 MG TAB has ranged from a low of $0.1857 (Nov 20, 2024) to a high of $0.6705 (Nov 15, 2023), with a median of $0.3802 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHETAM 7.5 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of DEXTROAMP-AMPHETAM 7.5 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DEXTROAMP-AMPHETAM 7.5 MG TAB?
DEXTROAMP-AMPHETAM 7.5 MG TAB (NDC 42858072201) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.